Introduction
This trial represents a major milestone in our research, being the first randomized controlled trial to investigate whether supplementation with all three macular carotenoids lutein, zeaxanthin, and meso-zeaxanthin could improve vision in patients with Alzheimer’s disease. Building on previous exploratory work demonstrating carotenoid deficiencies and visual impairment in this group, we aimed to test whether targeted nutrition could provide real clinical benefit.
Why was the research undertaken?
Our earlier observational studies revealed significantly lower macular carotenoid levels in Alzheimer’s patients, which correlated with poorer contrast sensitivity and reduced vision-related quality of life. Given that these carotenoids are also present in the brain and have antioxidant and anti-inflammatory properties, we hypothesized that supplementation might improve eye health in people living with mild to moderate Alzheimer’s disease.
How was the study conducted?
We ran a 12-month, double-blind, placebo-controlled trial with patients diagnosed with Alzheimer’s disease. Participants were randomized to receive either a daily supplement containing lutein, zeaxanthin, and meso-zeaxanthin, or a placebo. We assessed visual function and gathered feedback from caregivers using validated clinical assessment tools.
What were the results?
The supplemented group experienced statistically significant improvements in visual function especially contrast sensitivity outcomes compared to placebo. Caregivers reported noticeable improvements in daily functioning. The supplement was well tolerated with no adverse effects reported throughout the study.
What is the societal benefit?
This study provided compelling evidence that nutritional supplementation with macular carotenoids can positively impact vision in patients with Alzheimer’s disease. It supports the potential role of this intervention as a safe and accessible addition to current management strategies for Alzheimer’s. The findings also highlight the urgent need for further research into how targeted nutrition can benefit not just eye health, but cognitive function as well. These results prompted us to explore further, leading to a reformulation that included omega-3 fatty acids and vitamin E. We later tested this updated formula in subsequent studies.
